NO922961L - Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav - Google Patents

Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav

Info

Publication number
NO922961L
NO922961L NO92922961A NO922961A NO922961L NO 922961 L NO922961 L NO 922961L NO 92922961 A NO92922961 A NO 92922961A NO 922961 A NO922961 A NO 922961A NO 922961 L NO922961 L NO 922961L
Authority
NO
Norway
Prior art keywords
solutions
parts
procedures
preparing
pharmaceutical composition
Prior art date
Application number
NO92922961A
Other languages
English (en)
Norwegian (no)
Other versions
NO922961D0 (no
Inventor
Erno Orban
Laszlone Tomori
Maria Kuthy
Tibor Balogh
Laszlo Jaszlits
Imre Moravcsik
Istvan Kovacs
Istvanne Jusztin
Sandor Jancso
Erzsebet Takacs
Tamasne Kiss
Antalne Kovacs
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of NO922961D0 publication Critical patent/NO922961D0/no
Publication of NO922961L publication Critical patent/NO922961L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO92922961A 1990-11-27 1992-07-27 Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav NO922961L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU907653A HU208491B (en) 1990-11-27 1990-11-27 Process for producing oral pharmaceutical composition containing cyclosporin
PCT/HU1991/000050 WO1992009299A1 (en) 1990-11-27 1991-11-27 Oral pharmaceutical composition containing cyclosporin and process for preparing same

Publications (2)

Publication Number Publication Date
NO922961D0 NO922961D0 (no) 1992-07-27
NO922961L true NO922961L (no) 1992-09-23

Family

ID=10972318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922961A NO922961L (no) 1990-11-27 1992-07-27 Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav

Country Status (18)

Country Link
US (1) US5430017A (de)
EP (1) EP0512109B1 (de)
JP (1) JPH082795B2 (de)
AT (1) ATE129898T1 (de)
AU (1) AU651154B2 (de)
CA (1) CA2072983A1 (de)
CS (1) CS230492A3 (de)
DE (1) DE69114476T2 (de)
DK (1) DK0512109T3 (de)
FI (1) FI923385A0 (de)
HU (1) HU208491B (de)
IL (1) IL100162A (de)
MX (1) MX9102243A (de)
NO (1) NO922961L (de)
NZ (1) NZ240762A (de)
PT (1) PT99623A (de)
WO (1) WO1992009299A1 (de)
ZA (1) ZA919352B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
SK164796A3 (en) 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
WO1997007787A1 (en) * 1995-08-25 1997-03-06 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
AU764599B2 (en) * 1995-08-25 2003-08-21 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
SK285019B6 (sk) 1997-01-30 2006-04-06 Novartis Ag Tvrdá želatínová tobolka
NZ337316A (en) * 1997-03-12 2001-06-29 Abbott Lab Hydrophilic binary systems comprising cyclosporine, hydrophilic phase and a surfactant for the administration of cyclosporine
US5891845A (en) * 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
ATE404172T1 (de) 1998-12-30 2008-08-15 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE290460C (de) *
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
CA1323306C (en) * 1987-03-05 1993-10-19 Mircea C. Popescu Pharmacological agent-lipid solution preparation
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
CH679277A5 (de) * 1989-02-09 1992-01-31 Sandoz Ag
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine

Also Published As

Publication number Publication date
FI923385A7 (fi) 1992-07-27
ATE129898T1 (de) 1995-11-15
EP0512109A1 (de) 1992-11-11
JPH05503306A (ja) 1993-06-03
JPH082795B2 (ja) 1996-01-17
FI923385L (fi) 1992-07-27
AU651154B2 (en) 1994-07-14
PT99623A (pt) 1992-12-31
NZ240762A (en) 1993-05-26
DK0512109T3 (da) 1995-12-11
AU8944091A (en) 1992-06-25
EP0512109B1 (de) 1995-11-08
NO922961D0 (no) 1992-07-27
ZA919352B (en) 1992-09-30
FI923385A0 (fi) 1992-07-27
WO1992009299A1 (en) 1992-06-11
IL100162A (en) 1995-11-27
IL100162A0 (en) 1992-08-18
DE69114476D1 (de) 1995-12-14
MX9102243A (es) 1992-07-08
DE69114476T2 (de) 1996-04-18
CS230492A3 (en) 1992-12-16
HUT60929A (en) 1992-11-30
HU208491B (en) 1993-11-29
HU907653D0 (en) 1991-06-28
US5430017A (en) 1995-07-04
CA2072983A1 (en) 1992-05-28

Similar Documents

Publication Publication Date Title
NO922961L (no) Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav
AU637110B2 (en) Process for reducing the crystal size of ondanestron hydrochloride dihydrate
HU224496B1 (hu) Pirrolidin-3-il-alkil-piperidin-származékok és e vegyületeket tartalmazó gyógyászati készítmények
NO961136L (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
ES2002140A6 (es) Procedimiento para producir preparados de derivados de acido arilpropionico resorbibles por via transdermal y acuosos
ATE1288T1 (de) Amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel.
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
DK92781A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
ES2155535T3 (es) Inhibidores de sintesis de apoliproteina b.
NO870560D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
FI894899A0 (fi) Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi
DK0808303T3 (da) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreceptorantagonister
IE43693L (en) Androstane derivatives
EP0315401A3 (de) Xanthinderivate, ihre Herstellung und diese enthaltende pharmazeutische Präparate
DE202016008851U1 (de) Gebrauchsfertige Bortezomib-Lösung
ATE35812T1 (de) Gamma-butyrolactonderivate, verfahren zur herstellung derselben und dieselben als aktive bestandteile enthaltende immunomodulierende zubereitungen.
WO2024192323A3 (en) Ophthalmic cream formulations and their uses
ATE160938T1 (de) Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
US4406888A (en) Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
AU556962B2 (en) Pyridobenzodiazepinone derivatives
KR920021558A (ko) 부분입체이성질체적으로 순수한 1-(2,2-디메틸프로피오닐옥시)-에틸-3-세펨-4-카복실레이트의 결정성 산부가염
AU4831279A (en) New compounds
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
GB2021581A (en) Stabilisation of PGl2 derivatives